1-1 of 1
A. Al Jefri
Close
Sort by
Journal Articles

Deferasirox (Exjade®, ICL670) Is Effective and Tolerable in β-Thalassemia Patients with High Iron Burden and History of Inadequate Chelation Therapy.

A. Taher, A. El-Beshlawy, A. Al Jefri, M. Elalfy, K. Al Zir, S. Daar, G. Damanhouri, U. Krahn, D. Hadler
Journal: Blood
Blood (2006) 108 (11): 3823.
https://doi.org/10.1182/blood.V108.11.3823.3823
Published: 2006